First Horizon Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.01M Sell
11,538
-455
-4% -$38.6K 0.03% 254
2025
Q1
$1.08M Sell
11,993
-10,056
-46% -$900K 0.03% 246
2024
Q4
$1.76M Sell
22,049
-4,702
-18% -$407K 0.05% 212
2024
Q3
$2.41M Sell
26,751
-132,466
-83% -$11.1M 0.07% 194
2024
Q2
$12.5M Buy
159,217
+4,504
+3% +$369K 0.38% 87
2024
Q1
$13.5M Buy
154,713
+1,031
+0.7% +$88K 0.42% 82
2023
Q4
$12.7M Buy
153,682
+4,637
+3% +$353K 0.42% 78
2023
Q3
$11.7M Buy
149,045
+7,556
+5% +$633K 0.42% 77
2023
Q2
$12.5M Buy
141,489
+1,573
+1% +$135K 0.43% 72
2023
Q1
$11.3M Buy
139,916
+19,713
+16% +$1.61M 0.4% 78
2022
Q4
$9.34M Buy
120,203
+3,011
+3% +$244K 0.34% 89
2022
Q3
$9.46M Buy
117,192
+4,722
+4% +$424K 0.38% 85
2022
Q2
$10.1M Buy
112,470
+89,801
+396% +$9.1M 0.36% 88
2022
Q1
$2.52M Sell
22,669
-73,146
-76% -$7.73M 0.14% 174
2021
Q4
$9.91M Buy
95,815
+7,469
+8% +$865K 0.3% 105
2021
Q3
$11.1M Buy
88,346
+7,817
+10% +$1.01M 0.36% 87
2021
Q2
$9.99M Buy
80,529
+2,096
+3% +$263K 0.54% 59
2021
Q1
$9.27M Buy
78,433
+4,116
+6% +$482K 0.54% 58
2020
Q4
$8.71M Buy
74,317
+1,199
+2% +$132K 0.58% 56
2020
Q3
$7.6M Buy
73,118
+2,630
+4% +$264K 0.57% 55
2020
Q2
$6.46M Buy
70,488
+3,473
+5% +$333K 0.51% 60
2020
Q1
$6.04M Buy
67,015
+3,409
+5% +$363K 0.56% 50
2019
Q4
$7.21M Buy
63,606
+1,658
+3% +$182K 0.53% 54
2019
Q3
$6.73M Sell
61,948
-2,020
-3% -$211K 0.52% 52
2019
Q2
$6.23M Buy
63,968
+5,375
+9% +$491K 0.48% 55
2019
Q1
$5.34M Buy
58,593
+43,025
+276% +$3.85M 0.43% 63
2018
Q4
$1.42M Buy
15,568
+723
+5% +$67.6K 0.13% 147
2018
Q3
$1.46M Sell
14,845
-1,020
-6% -$94.3K 0.11% 159
2018
Q2
$1.36M Buy
15,865
+11,100
+233% +$927K 0.11% 158
2018
Q1
$382K Hold
4,765
0.04% 224
2017
Q4
$385K Hold
4,765
0.04% 236
2017
Q3
$370K Sell
4,765
-400
-8% -$33.2K 0.04% 232
2017
Q2
$458K Sell
5,165
-2,733
-35% -$230K 0.05% 209
2017
Q1
$636K Sell
7,898
-1,096
-12% -$85.6K 0.07% 189
2016
Q4
$777K Sell
8,994
-1,346
-13% -$106K 0.1% 175
2016
Q3
$888K Buy
10,340
+20
+0.2% +$1.74K 0.11% 168
2016
Q2
$894K Sell
10,320
-399
-4% -$32.3K 0.12% 161
2016
Q1
$807K Sell
10,719
-81
-0.8% -$6.1K 0.09% 174
2015
Q4
$830K Sell
10,800
-1,107
-9% -$83.3K 0.15% 145
2015
Q3
$797K Sell
11,907
-1,275
-10% -$93.9K 0.12% 158
2015
Q2
$976K Sell
13,182
-2,422
-16% -$185K 0.14% 151
2015
Q1
$1.22M Buy
15,604
+4,065
+35% +$308K 0.18% 139
2014
Q4
$833K Sell
11,539
-6
-0.1% -$417 0.13% 166
2014
Q3
$715K Sell
11,545
-200
-2% -$12.7K 0.11% 177
2014
Q2
$748K Buy
11,745
+25
+0.2% +$1.52K 0.11% 185
2014
Q1
$721K Sell
11,720
-174
-1% -$10.1K 0.1% 178
2013
Q4
$681K Buy
11,894
+23
+0.2% +$1.3K 0.1% 176
2013
Q3
$632K Buy
11,871
+11,623
+4,687% +$625K 0.1% 178
2013
Q2
$13K Buy
+248
New +$12.3K 0.01% 460

Other funds holding MDT

First Horizon Advisors's MDT Position: Q2 2025 in Review

First Horizon Advisors reduced its Medtronic (MDT) stake by 3.8% in Q2 2025, selling an estimated $38.6K and leaving 11,538 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #254.

First Horizon Advisors first reported a position in MDT in Q2 2013 and has held it in 49 quarters since. The position peaked at $13.5M in Q1 2024. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • First Horizon Advisors held 11,538 shares of Medtronic worth $1.01M as of Q2 2025.
  • First Horizon Advisors sold 455 Medtronic shares in Q2 2025, an estimated $38.6K.
  • Medtronic made up 0.03% of First Horizon Advisors's portfolio in Q2 2025, its #254 holding.
  • First Horizon Advisors first reported a position in Medtronic in Q2 2013 and has held it in 49 quarters since.
  • First Horizon Advisors's Medtronic position peaked at $13.5M in Q1 2024.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.